A detailed history of Quest Partners LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Quest Partners LLC holds 9,256 shares of CORT stock, worth $485,662. This represents 0.04% of its overall portfolio holdings.

Number of Shares
9,256
Previous 5,266 75.77%
Holding current value
$485,662
Previous $171 Million 150.37%
% of portfolio
0.04%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$29.51 - $46.26 $117,744 - $184,577
3,990 Added 75.77%
9,256 $428 Million
Q2 2024

Aug 06, 2024

BUY
$22.21 - $34.48 $22,032 - $34,204
992 Added 23.21%
5,266 $171 Million
Q1 2024

May 09, 2024

SELL
$21.1 - $27.46 $90,160 - $117,336
-4,273 Reduced 49.99%
4,274 $108 Million
Q4 2023

Feb 09, 2024

BUY
$24.82 - $32.88 $212,136 - $281,025
8,547 New
8,547 $278 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.62B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.